HOSPITALIZATION AND EXACERBATION ESTIMATES OF EFGARTIGIMOD VS. CONVENTIONAL THERAPY IN GENERALIZED MYASTHENIA GRAVIS PATIENTS: A POST-HOC ANALYSIS OF THE PHASE 3 ADAPT STUDY

被引：0
|
作者：
Qi, C. [1 ]
Dewilde, S. [2 ]
Gelinas, D. [1 ]
Brauer, E. [1 ]
Phillips, G. [1 ]
机构：
[1] Argenx Inc, Boston, MA USA
[2] SHE, Brussels, Vbr, Belgium
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO135
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [1] Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis
    Dewilde, Sarah
    Griffiths, Alison
    Qi, Cynthia Z.
    Phillips, Glenn
    Gelinas, Deborah
    Brauer, Edward
    Mantegazza, Renato
    Howard, James F.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 466
  • [2] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2021, 96 (15)
  • [3] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: phase 3 adapt study results
    Mantegazza, R.
    Bril, V.
    Vu, T.
    Karam, C.
    Peric, S.
    Margania, T.
    Murai, H.
    Biliska, M.
    Shakarishvili, R.
    Smilowski, M.
    Guglietta, A.
    Ulrichts, P.
    Vangeneugden, T.
    Utsugisawa, K.
    Verschuuren, J.
    Howard, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 80 - 80
  • [4] Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results
    Mantegazza, Renato
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Howard, James
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [5] Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study
    Bril, Vera
    Howard Jr, James F.
    Karam, Chafic
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Utsugisawa, Kimiaki
    Ulrichts, Peter
    Brauer, Edward
    Zhao, Sihui
    Mantegazza, Renato
    Vu, Tuan
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (01)
  • [6] TREATMENT OF PATIENTS WITH MYASTHENIA GRAVIS WITH EFGARTIGIMOD: RESULTS OF THE PHASE 3 ADAPT STUDY
    Howard, J.
    Vu, T.
    Bril, V.
    Peric, S.
    Verschuuren, J.
    Mantegazza, R.
    Murai, H.
    Ulrichts, P.
    Guglietta, A.
    de Haard, H.
    Parys, W.
    Beydoun, S.
    Pasnoor, M.
    Karam, C.
    Muppidi, Sr
    Bertorini, T.
    Bhavaraju-Sanka, R.
    Li, Y.
    MUSCLE & NERVE, 2020, 62 : S125 - S126
  • [7] ROZANOLIXIZUMAB IN PATIENTS AGED ≥65 YEARS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE PHASE 3 MYCARING STUDY
    Vu, Tuan
    Habib, Ali A.
    Pascuzzi, Robert M.
    Sacconi, Sabrina
    Grimson, Fiona
    Pulido-Valdeolivas, Irena
    Tarancon, Thais
    Bril, Vera
    MUSCLE & NERVE, 2024, 70 (03) : 663 - 664
  • [8] Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales: Results of the Phase 3 ADAPT Study
    Bril, Vera
    Murai, HIroyuki
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Margania, Temur
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    Howard, James F., Jr.
    ANNALS OF NEUROLOGY, 2021, 90 : S28 - S28
  • [9] EXAMINATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: SUBGROUP ANALYSIS OF PHASE 3
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Pasnoor, Mamatha
    Sacca, Francesco
    Meisel, Andreas
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2021, 64 : S5 - S5
  • [10] A PHASE-3B OPEN-LABEL STUDY TO FURTHER INDIVIDUALIZE EFGARTIGIMOD TREATMENT OPTIONS FOR PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Gwathmey, Kelly
    Sahagian, Gregory
    Hussain, Yessar
    Feinberg, Marc
    Habib, Ali
    Skripuletz, Thomas
    Ruck, Tobias
    Brauer, Edward
    Gelinas, Deborah
    Zhao, Sihui
    Bogatyreva, Anna
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S141 - S142
12345